# Prophylaxis Failure and Successful Management of Delayed-Onset Malaria with Renal Complications: A Case Report with Oral Artemether-Lumefantrine Treatment

**Authors:** Ilir Tolaj, Gramoz Bunjaku, Murat Mehmeti, Yllka Begolli

PMC · DOI: 10.3390/reports6040053 · Reports · 2023-11-08

## TL;DR

A 55-year-old patient developed severe malaria with kidney issues despite taking doxycycline, and recovered with oral artemether-lumefantrine and dialysis.

## Contribution

Highlights doxycycline prophylaxis failure and successful management of severe malaria with renal complications using oral treatment.

## Key findings

- Doxycycline prophylaxis failed in a patient who developed severe Plasmodium falciparum malaria.
- Oral artemether-lumefantrine and supportive care, including dialysis, led to clinical improvement.
- The case emphasizes the importance of timely diagnosis and treatment in non-endemic countries.

## Abstract

This case report presents a critical clinical scenario involving a 55-year-old patient who developed severe Plasmodium falciparum malaria with renal complications despite receiving doxycycline prophylaxis while traveling in a malaria-endemic region. The case emphasizes the potential failure of doxycycline prophylaxis and highlights the importance of considering malaria in patients with a history of travel to endemic areas, even if they have adhered to prophylactic treatment. The patient’s clinical presentation included fever, extreme fatigue, and loss of consciousness, leading to hospitalization. Laboratory findings revealed severe anemia, elevated liver enzymes, and impaired renal function, consistent with the criteria for severe malaria. The diagnosis was confirmed by the presence of Plasmodium falciparum parasites on thin blood smears. Due to limited access to parenteral antimalarial medications in Kosovo, the patient received oral artemether-lumefantrine, resulting in clinical improvement. Supportive care and dialysis played a vital role in the patient’s recovery. This case report underscores the need for increased awareness of prophylaxis failure, the challenges of managing severe malaria in non-endemic countries, and the importance of timely and appropriate interventions to improve outcomes in severe malaria cases, particularly those with renal involvement.

## Linked entities

- **Chemicals:** doxycycline (PubChem CID 54671203), artemether-lumefantrine (PubChem CID 6450800)
- **Diseases:** malaria (MONDO:0005136)
- **Species:** Plasmodium falciparum (taxon 5833)

## Full-text entities

- **Diseases:** Malaria (MESH:D008288), Renal Complications (MESH:D007674), fever (MESH:D005334), Plasmodium falciparum malaria (MESH:D016778), loss of consciousness (MESH:D014474), anemia (MESH:D000740), renal involvement (MESH:C565423), fatigue (MESH:D005221)
- **Chemicals:** Artemether-Lumefantrine (MESH:D000077611), doxycycline (MESH:D004318)
- **Species:** Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12225451/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12225451/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12225451/full.md

---
Source: https://tomesphere.com/paper/PMC12225451